NIH Weekly Funding Opportunities and Policy Notices
Notice NOT-MH-17-046 from the NIH Guide for Grants and Contracts
Notice NOT-MH-17-047 from the NIH Guide for Grants and Contracts
Funding Opportunity RFA-MD-17-006 from the NIH Guide for Grants and Contracts. The purpose of the Research Centers in Minority Institutions (RCMI) Program is to expand the national capacity for research in the health sciences by providing cooperative agreement support to institutions that offer doctorate degrees in the health professions or in a health-related science and have a historical and current commitment to educating underrepresented students, and for institutions that deliver health care services, providing clinical services to medically underserved communities. The primary goals of the RCMI specialized centers are to: (1) enhance institutional research capacity within the areas of basic biomedical, behavioral, and/or clinical research; (2) enable all levels of investigators to become more successful in obtaining competitive extramural support, especially from NIH, particularly on diseases that disproportionately impact minority and other health disparity populations; (3) foster environments conducive to career enhancement with a special emphasis on development of new and early career investigators; (4) enhance the quality of all scientific inquiry and promote research on minority health and health disparities; and (5) establish sustainable relationships with community-based organizations that will partner with the RCMI Institution.
Funding Opportunity PAR-17-471 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement (FOA) is to support bi-phasic developmental, discovery-driven, or hypothesis-driven research focused on innovative strategies to detect HIV either within the first two weeks of infection or to monitor viral rebound after stopping or developing resistance to antiretroviral therapy. Applications should propose simple diagnostic tools that would be feasible for a self-testing platform to allow untrained individuals to detect HIV. Interdisciplinary collaborations that include biomedical, physical, and behavioral sciences are highly encouraged.
Funding Opportunity PAR-17-470 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement (FOA) is to support US-Caribbean collaborative research to develop or extend cohort or surveillance studies on chronic disease in the Caribbean region that are aligned with existing publicly available US datasets. The intent is for these cohorts or datasets to be used for ongoing comparative research to better understand the health of Caribbean immigrant populations in the US.
Notice NOT-DA-17-054 from the NIH Guide for Grants and Contracts
Notice NOT-DK-17-018 from the NIH Guide for Grants and Contracts
Notice NOT-GM-17-020 from the NIH Guide for Grants and Contracts
Notice NOT-HG-17-016 from the NIH Guide for Grants and Contracts
Notice NOT-NS-18-007 from the NIH Guide for Grants and Contracts
Funding Opportunity RFA-AA-18-006 from the NIH Guide for Grants and Contracts. The National Institute on Alcohol Abuse and Alcoholism (NIAAA) seeks to continue support of the previously funded program on Translational Research in Alcoholic Hepatitis to accelerate the discovery and validation of new diagnostic and treatment options for patients with Alcoholic Hepatitis (AH). This initiative, via a set of five FOAs, aims to enhance and consolidate the existing program into AH Clinical and Translational Network, hereafter termed AH Network. This consolidated program will consist of 1) Clinical component, 2) Data Coordinating Center, 3) Translational component, and 4) Basic and pre-clinical component. Through this FOA, applications are sought to conduct basic and pre-clinical studies addressing high impact areas in Alcoholic Hepatitis under the UH2/UH3 Phase Innovation Awards Cooperative Agreement funding mechanism.
Funding Opportunity RFA-AA-18-005 from the NIH Guide for Grants and Contracts. The National Institute on Alcohol Abuse and Alcoholism (NIAAA) seeks to continue support of the previously funded program on Translational Research in Alcoholic Hepatitis to accelerate the discovery and validation of new diagnostic and treatment options for patients with Alcoholic Hepatitis (AH). This initiative, via a set of five FOAs, aims to enhance and consolidate the existing program into AH Clinical and Translational Network, hereafter termed AH Network. This consolidated program will consist of 1) Clinical component, 2) Data Coordinating Center, 3) Translational component, and 4) Basic and pre-clinical component. Through this FOA, applications are sought to conduct investigator-initiated single-center feasibility and pilot studies aimed to optimize critical elements for full-scale clinical trial in patients with AH under the U01 Research Project Cooperative Agreements funding mechanism.
Funding Opportunity RFA-AA-18-004 from the NIH Guide for Grants and Contracts. The National Institute on Alcohol Abuse and Alcoholism (NIAAA) seeks to continue support of the previously funded program on Translational Research in Alcoholic Hepatitis to accelerate the discovery and validation of new diagnostic and treatment options for patients with Alcoholic Hepatitis (AH). This initiative, via a set of five FOAs, aims to enhance and consolidate the existing program into AH Clinical and Translational Network, hereafter termed AH Network. This consolidated program will consist of 1) Clinical component, 2) Data Coordinating Center, 3) Translational component, and 4) Basic and pre-clinical component. Through this FOA, applications are sought for a Data Coordinating Center (DCC) to provide expert assistance to support the AH Network on data management, statistical analysis, biospecimen collection, and logistical support under the U24 Resource-Related Research Projects Cooperative Agreements funding mechanism.
Funding Opportunity RFA-AA-18-003 from the NIH Guide for Grants and Contracts. The National Institute on Alcohol Abuse and Alcoholism (NIAAA) seeks to continue support of the previously funded program on Translational Research in Alcoholic Hepatitis to accelerate the discovery and validation of new diagnostic and treatment options for patients with Alcoholic Hepatitis (AH). This initiative, via a set of five FOAs, aims to enhance and consolidate the existing program into AH Clinical and Translational Network, hereafter termed AH Network. This consolidated program will consist of 1) Clinical component, 2) Data Coordinating Center, 3) Translational component, and 4) Basic and pre-clinical component. Through this FOA, applications are sought to conduct translational studies aimed on improving various aspects of AH diagnosis and intervention under the U01 Cooperative Agreements funding mechanism.
Funding Opportunity RFA-AA-18-002 from the NIH Guide for Grants and Contracts. The National Institute on Alcohol Abuse and Alcoholism (NIAAA) seeks to continue support of the previously funded program on Translational Research in Alcoholic Hepatitis to accelerate the discovery and validation of new diagnostic and treatment options for patients with Alcoholic Hepatitis (AH). This initiative, via a set of five FOAs, aims to enhance and consolidate the existing program into AH Clinical and Translational Network, hereafter termed AH Network. This consolidated program will consist of 1) Clinical component, 2) Data Coordinating Center, 3) Translational component, and 4) Basic and pre-clinical component. Through this FOA, applications are sought to conduct investigator-initiated collaborative late phase clinical trials and observational studies in patients with AH under the U01 Collaborative Cooperative Agreements funding mechanism.
Notice NOT-GM-17-018 from the NIH Guide for Grants and Contracts
Notice NOT-AI-17-038 from the NIH Guide for Grants and Contracts
Notice NOT-RM-17-038 from the NIH Guide for Grants and Contracts
Funding Opportunity RFA-AA-18-007 from the NIH Guide for Grants and Contracts. December 7, 2017, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on December 7, 2017 No late applications will be accepted for this Funding Opportunity Announcement. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
Notice NOT-HL-17-533 from the NIH Guide for Grants and Contracts